Creating cost-effective flu shot programs.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to D Epstein.
Explore the source record for details and available documents.
OBJECTIVE: This prospective study examines coverage levels for immunization of two-year-old children in a large private pediatric practice, and delineates the frequency of missed opportunities for vaccination. SETTING: A private single-specialty group pediatric practice in a suburban locale. DESIGN: With the aid of our office billing computer, 218 children between the ages of 21 and 24 months who had ever received medical care in our practice were identified. A manual chart review was performed to identify those children no longer receiving care from us. Of the 189 patients remaining, the immunization records in the patients' charts were compared to the State of Delaware immunization registry to identify those who had not received the full panel of recommended vaccines. Those charts were examined to identify reasons for underimmunization. No patient recall was performed. The charts of underimmunized children were reexamined five months later to determine how many had become fully immunized. RESULTS: On initial review, 86 percent of 21-24 month old children in our practice had received all recommended vaccines. Only 15 percent of the underimmunized children had had a missed opportunity for vaccination in the initial chart review. About half of the underimmunized patients received their missing vaccines over the next five months, yielding an eventual immunization rate of 94 percent. Only two of the 11 children still underimmunized by the end of the study (aged 26 to 29 months) had appeared for an 18 month or a 24 month well child visit; only four of the 11 had had a missed opportunity to receive immunizations during the five month study period. A subsequent chart review showed that 90 percent of our patients were up-to-date at 24 months of age. CONCLUSIONS: Achievement of a 90 percent immunization rate for two year old children is possible in a large private practice. Most underimmunized children in our practice had failed to appear for recommended well visits; a minority experienced missed opportunities for immunization.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
PURPOSE: To determine the effect of patient age, postoperative time, ablation zone diameter and depth, attempted correction, and corneal topography on postoperative corneal epithelial thickness after photorefractive keratectomy (PRK). SETTING: Private clinic and university hospital, Stockholm, Sweden. METHODS: This retrospective, unmasked study comprised 136 myopic patients treated unilaterally with PRK. Seventy eyes had been treated with the Summit excimer laser 27 months +/- 7 (SD) earlier using ablation zone diameters of 4.1 to 5.0 mm. Sixty-six eyes had been treated with the VISX excimer laser 6 +/- 3 months earlier using a 6.0 mm zone diameter. The untreated fellow eyes served as controls. Epithelial thickness was measured at a standardized central corneal area with a modified optical pachymeter, and corneal topography was determined using computerized videokeratoscopy. RESULTS: In the Summit group, the epithelial layer in the PRK eyes was 12.0 microns (21%) thicker than in the control eyes (P < .001; 95% confidence interval [CI] 9.35 to 14.3 microns). This thickness differential correlated significantly with increased ablation depth and attempted correction. In the VISX group, the epithelium in the treated eyes was 7.0 microns (7%) thinner (P = .0009; 95% CI -1.9 to -6.7 microns) and thickness did not correlate with ablation depth or attempted correction. There was no correlation between epithelial hyperplasia and patient age or postoperative follow-up. With the laser groups combined, epithelial hyperplasia was greater with smaller zone sizes and a greater rate of change in power at the edge of the ablation zone. CONCLUSION: The factors associated with an increase in epithelial thickness were small ablation zones, greater attempted corrections, and deeper ablations. Larger, smoother ablation profiles may result in less epithelial hyperplasia.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Epithelial hyperplasia has been found to occur after photorefractive keratectomy in eyes treated with small (5 mm or less) ablation zone diameters with the Summit laser, but not with large zones (6 mm) with the VISX laser (Gauthier et al. 1995a). The aim of this study was to further investigate the effect of surgical parameters on epithelial hyperplasia by comparing eyes treated with the same zone diameter but two different lasers. We examined 11 subjects who had photorefractive keratectomy for myopia performed with 5 mm ablation zones with the Summit excimer laser in one eye and the VISX 20/20 laser in the fellow eye an average of 21 months previously. Epithelial thickness and corneal topography were measured. The mean epithelial thickness was not statistically different (p = 0.083) between the eyes treated with the Summit (66 +/- 12 microns) and VISX (60 +/- 14 microns) lasers. Postoperative corneal dioptric power showed a similar profile between the two eyes at the edge of the zone, with the VISX-treated corneas being more shallow centrally. There was a trend towards greater epithelial thickness with deeper ablations. This study supports the hypothesis that epithelial hyperplasia is dependent on ablation zone diameter and ablation depth.
AIM: To determine the relation between epithelial hyperplasia and regression of effect after photorefractive keratectomy (PRK). METHODS: Seventy unilaterally treated patients with PRK were examined. All eyes had been treated with the Summit excimer laser 27 (SD 7) months previously with zone diameters of 4.1 to 5.0 mm. The untreated fellow eyes served as controls. Epithelial thickness was measured centrally with a thin slit optical pachometer and manifest subjective refraction was performed. RESULTS: The epithelium was 21% thicker in the treated eye (p < 0.0001). The relation between refractive regression and epithelial hyperplasia was significant (r = 0.41; p < 0.001). CONCLUSIONS: Epithelial hyperplasia after PRK correlated with the myopic shift (including hyperopia reduction) after treatment with the Summit laser. A model is proposed suggesting that both subepithelial and epithelial layers contribute to regression in the Summit treated eyes with 18 microns of epithelial hyperplasia contributing each dioptre of regression.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
In an effort to isolate novel genes involved in inflammation and/or mast cell activation, we have used a combination of differential screening and subtractive hybridization to isolate genes whose expression are induced upon activation of a transformed rat mast cell line. One of the isolated clones, pMCA-32, contained an open reading frame of 278 amino acids that included a putative hydrophobic transmembrane domain, a cysteine rich Ig-like extracellular domain, and a cytoplasmic domain containing three consensus SH2-domain phosphotyrosine binding sites. The MCA-32 gene is also highly conserved between rat and mouse, with the two coding regions being 73% identical. Although the MCA-32 coding region did not contain an obvious signal peptide, MCA-32 protein was detected on the surface of rat mast cells, and the cloned cDNA produced a cell surface protein when expressed in COS-7 cells. MCA-32 RNA from both mouse and rat undergoes alternative splicing, producing an mRNA containing an in-frame deletion of the TM domain, suggesting that a form of MCA-32 protein may be secreted. MCA-32 mRNA expression was up-regulated upon activation of RBL-2H3 cells and was highly abundant in primary peritoneal mast cells. Expression of MCA-32 RNA was only observed in primary and transformed mast cells from rat, while in the mouse MCA-32, RNA was also produced in significant amounts by a number of transformed monocyte cell lines. Thus, MCA-32 is a novel surface protein whose structure and expression suggest roles in the development and/or activation of mast cells and monocytes.
Explore the source record for details and available documents.
The use of lasers to correct refractive errors has become an established clinical procedure in many countries. Excimer laser photorefractive keratectomy (PRK) has been performed on an estimated 400,000 to 500,000 eyes worldwide. For myopia up to about 6.0 D, PRK appears to be generally safe, exhibiting acceptable accuracy, predictability, and stability. Complications of PRK can occur intraoperatively, and early or late postoperatively. For higher degrees of myopia, laser in situ keratomileusis may prove to be a more appropriate procedure, but long-term follow-up is needed. Hyperopic PRK and holmium:yttrium-aluminum-garnet thermokeratoplasty are still considered investigational methods, and for newer technologies, such as solid-state lasers, human trials are being launched.
Explore the source record for details and available documents.
The confines of our knowledge with respect to excimer laser photorefractive keratectomy are particularly manifest in two areas: the effects of the excimer on the corneal tissue, especially in the course of the wound healing process; and the optical aberrations caused by the laser treatment through structural alterations in a previously clear cornea. The criteria currently used to evaluate the outcome of excimer refractive surgery are not adequate. More stringent and nuanced assessments are needed to expand the frontiers of our knowledge.
Regression of effect is a well-established complication of excimer laser photorefractive keratectomy for the correction of myopia. In 17 eyes retreated with excimer photorefractive keratectomy, minimum follow-up time was six months. Mean (+/- SD) refraction at six months postoperatively was -0.97 +/- 2.10 diopters, significantly different (P < .01) from the pre-retreatment mean of -2.91 +/- 0.86 diopters. The 11 best eyes (six-month refraction < -1.00 diopter) had a mean refraction of +0.32 +/- 0.67 diopter. At six months after retreatment, 64.7% had an uncorrected visual acuity greater than or equal to 20/40, and 58.8% were within 1.00 diopter of emmetropia. Two eyes showed a loss of one to two Snellen lines at six months. There was no significant increase in mean haze after retreatment. While the percentage of eyes with uncorrected visual acuity greater than or equal to 20/40 and the percentage of eyes within 1.00 diopter of emmetropia were lower than in eyes which did not require retreatment, the results of this study indicate that the majority of photorefractive keratectomy regressions can be successfully retreated.